Eva Randárová
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
-
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
Papers in
- Biomaterials 15
- Nanoparticle-Based Drug Delivery 15
-
- Advanced Polymer Synthesis and Characterization 6
- Co-authors
- Tomáš Etrych (27 shared papers)Petr Chytil (12 shared papers)Karel Ulbrich (7 shared papers)Olga Janoušková (8 shared papers)Hideaki Nakamura (4 shared papers)Jun Fang (4 shared papers)Hiroshi Maeda (3 shared papers)Libor Kostka (5 shared papers)
In The Last Decade
Eva Randárová
28 papers receiving 437 citations
Peers
Comparison fields: 5 of 67
- Biomaterials 251
- Biomedical Engineering 191
- Polymers and Plastics 58
- Organic Chemistry 97
- Molecular Medicine 11
Countries citing papers authored by Eva Randárová
This map shows the geographic impact of Eva Randárová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Randárová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Randárová more than expected).
Fields of papers citing papers by Eva Randárová
This network shows the impact of papers produced by Eva Randárová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Randárová. The network helps show where Eva Randárová may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Randárová, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 57 | |
| 2 | 2014 | 41 | |
| 3 | 2016 | 38 | |
| 4 | 2015 | 31 | |
| 5 | 2017 | 31 | |
| 6 | 2016 | 31 | |
| 7 | 2018 | 25 | |
| 8 | 2020 | 22 | |
| 9 | 2019 | 18 | |
| 10 | 2020 | 16 | |
| 11 | 2020 | 15 | |
| 12 | 2020 | 13 | |
| 13 | 2021 | 12 | |
| 14 | 2017 | 12 | |
| 15 | 2020 | 11 | |
| 16 | 2023 | 9 | |
| 17 | 2022 | 9 | |
| 18 | 2020 | 8 | |
| 19 | 2023 | 7 | |
| 20 | 2018 | 7 |
About Eva Randárová
Eva Randárová is a scholar working on Biomaterials, Organic Chemistry, Molecular Biology, Oncology and Biomedical Engineering, having authored 29 papers that have together received 439 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (15 papers), Advanced Polymer Synthesis and Characterization (6 papers), Dendrimers and Hyperbranched Polymers (4 papers), Orthopedic Infections and Treatments (3 papers), Cancer therapeutics and mechanisms (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Nanoplatforms for cancer theranostics (3 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Biomaterials (251 citations), Biomedical Engineering (191 citations), Polymers and Plastics (58 citations), Organic Chemistry (97 citations) and Molecular Medicine (11 citations). Eva Randárová has collaborated with scholars based in Czechia, Japan and France. Frequent co-authors include Tomáš Etrych, Petr Chytil, Karel Ulbrich, Olga Janoušková, Hideaki Nakamura, Jun Fang, Hiroshi Maeda, Libor Kostka, Mamoru Haratake and Rafał Konefał. Their work appears in journals such as Journal of Controlled Release, Macromolecular Bioscience, Pharmaceutics, Molecular Pharmaceutics and European Journal of Pharmaceutics and Biopharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.